Q: A patient in the emergency room (ER) recently complained that she could hear the doctor and nurses discussing details of care of the patient in the bed next to hers. I understand that we should avoid disclosures, but the ER is often noisy and chaotic. How should we handle this situation?
This week’s Medicare updates include notification of a new interest rate for Medicare Overpayments and Underpayments, revisions to the Medicare Claims Processing Manual regarding payment of services furnished by qualified nonphysician anesthetists, a fact sheet for hospitals on the 2018 Medicare EHR Incentive Program payment adjustment, and more!
Patient care continues to move from the inpatient setting to outpatient. With this change, the challenge of securing comprehensive documentation that articulates the services rendered and the patient care provided now needs to extend across the care continuum.
Physician specialist payments could vary as much as 29% by 2020 under the Merit-Based Incentive Payment System (MIPS), according to the October 5 press release by Avalere. This is due to CMS’s proposal to include Medicare payments for Part B drugs in the calculation of the MIPS payment adjustment.
A one-size-fits-all approach to case management and patient care can be detrimental to patients and the case management profession, but so too can designing a new approach to care plans for every patient who walks through the door, according to an article in CMSA Today.
The Centers for Disease Control and Prevention (CDC), one of the Cooperating Parties responsible for the ICD-10-CM codes and guidelines, recently released a 2018 ICD-10-CM Official Guidelines for Coding and Reporting errata. Slight changes were made to the guidelines for diabetes, hypertension, and principal diagnosis selection.
Q: We are using a biosimilar for infliximab but it is manufactured by Merck/Samsung rather than Pfizer/Hospira. CMS requires that a manufacturer specific modifier be appended to the HCPCS code. Is there a new one for Merck/Samsung?